Before revision: Esketamine is a far more potent NMDA receptor pore blocker than arketamine
After revision: Esketamine is a , However, preclinical data suggest that (R)‐ketamine exerts greater potency and longer‐lasting antidepressant effects than (S)‐ketamine and that (R)‐ketamine has less detrimental side‐effects than (R,S)‐ketamine or (S)‐ketamine. more potent NMDA receptor pore blocker than arketamine